William Jacob  Savage net worth and biography

William Savage Biography and Net Worth

Insider of Disc Medicine

Will is the Chief Medical Officer and brings a decade of hematology and transfusion medicine clinical research experience, having worked across academic institutions, biopharma and biotech. Prior to joining Disc Medicine, he served as Senior Medical Director at Magenta Therapeutics, where he managed clinical development activities from preclinical through phase 2. Prior to Magenta Therapeutics, he was the Global Clinical Development Lead in Hematology at Shire/Takeda. Before transitioning to biotech/biopharma, Will was an Assistant Professor of Pathology at Harvard Medical School/Brigham and Women’s Hospital. He started his career at Johns Hopkins University School of Medicine, where he trained in pediatric hematology/oncology and transfusion medicine. He received his BA in Biochemistry magna cum laude from Columbia University, his MD with honors in research from Weill Cornell Medical College and his PhD in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health.

What is William Jacob Savage's net worth?

The estimated net worth of William Jacob Savage is at least $1.83 million as of November 25th, 2024. Savage owns 40,405 shares of Disc Medicine stock worth more than $1,833,175 as of April 25th. This net worth approximation does not reflect any other assets that Savage may own. Additionally, Savage receives a salary of $687,740.00 as Insider at Disc Medicine. Learn More about William Jacob Savage's net worth.

How old is William Jacob Savage?

Savage is currently 50 years old. There are 7 older executives and no younger executives at Disc Medicine. The oldest executive at Disc Medicine is Dr. Donald William Nicholson Ph.D., Executive Chairman, who is 66 years old. Learn More on William Jacob Savage's age.

What is William Jacob Savage's salary?

As the Insider of Disc Medicine, Inc., Savage earns $687,740.00 per year. The highest earning executive at Disc Medicine is Dr. John D. Quisel Esq., J.D., Ph.D., CEO, President & Director, who commands a salary of $903,460.00 per year. Learn More on William Jacob Savage's salary.

How do I contact William Jacob Savage?

The corporate mailing address for Savage and other Disc Medicine executives is 297 Boston Post Road #248, Wayland MA, 01778. Disc Medicine can also be reached via phone at 617-401-4400 and via email at ir@geminitherapeutics.com. Learn More on William Jacob Savage's contact information.

Has William Jacob Savage been buying or selling shares of Disc Medicine?

William Jacob Savage has not been actively trading shares of Disc Medicine over the course of the past ninety days. Most recently, William Jacob Savage sold 14,183 shares of the business's stock in a transaction on Monday, November 25th. The shares were sold at an average price of $65.45, for a transaction totalling $928,277.35. Following the completion of the sale, the insider now directly owns 40,405 shares of the company's stock, valued at $2,644,507.25. Learn More on William Jacob Savage's trading history.

Who are Disc Medicine's active insiders?

Disc Medicine's insider roster includes Mona Ashiya (Director), Kevin Bitterman (Director), Joanne Bryce (CFO), Jean Franchi (CFO), Rahul Khara (Insider), Brian Macdonald (Insider), John Quisel (CEO), William Savage (Insider), Pamela Stephenson (Insider), William White (Director), and Jonathan Yu (COO). Learn More on Disc Medicine's active insiders.

Are insiders buying or selling shares of Disc Medicine?

During the last year, insiders at the sold shares 21 times. They sold a total of 447,850 shares worth more than $25,068,128.17. The most recent insider tranaction occured on March, 24th when Director Mona Ashiya sold 5,738 shares worth more than $310,483.18. Insiders at Disc Medicine own 4.2% of the company. Learn More about insider trades at Disc Medicine.

Information on this page was last updated on 3/24/2025.

William Jacob Savage Insider Trading History at Disc Medicine

See Full Table

William Jacob Savage Buying and Selling Activity at Disc Medicine

This chart shows William Jacob Savage's buying and selling at Disc Medicine by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$1M$0$1MTotal Insider BuyingTotal Insider Selling

Disc Medicine Company Overview

Disc Medicine logo
Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and DISC-3405 for the treatment of polycythemia vera, and other hematologic disorders. The company's preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. Disc Medicine, Inc. was founded in 2017 and is headquartered in Watertown, Massachusetts.
Read More

Today's Range

Now: $45.75
Low: $45.19
High: $46.21

50 Day Range

MA: $48.73
Low: $34.28
High: $56.92

2 Week Range

Now: $45.75
Low: $25.64
High: $68.73

Volume

25,238 shs

Average Volume

344,473 shs

Market Capitalization

$1.58 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.77